Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Farrell

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
Journal of Gastroenterology and Hepatology|September 15, 1998
Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatmentR Lin, U Dutta, S Kaba, et al.
The Journal of Biological Chemistry|January 10, 1979
Incorporation of exogenous heme into hepatic cytochrome P-450 in vivoM A Correia, G C Farrell, R Schmid, et al.
Australian and New Zealand Journal of Medicine|June 27, 2000
Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control studyU Dutta, K Byth, J Kench, et al.
Journal of Viral Hepatitis|May 30, 2008
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver diseaseH Poustchi, A Mohamadkhani, S Bowden, et al.
Australian and New Zealand Journal of Medicine|June 1, 1991
Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?R Lin, M N Schoeman, P I Craig, et al.
International Journal of Obesity (2005)|March 10, 2011
Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie miceK S Bell-Anderson, L Aouad, H Williams, et al.
Journal of Gastroenterology and Hepatology|October 30, 1998
Molecular epidemiology of hepatitis C in AustraliaS Kaba, U Dutta, K Byth, et al.
The Medical Journal of Australia|September 3, 1990
Does hepatitis C virus play a role in "non-viral" chronic liver disease?C Liddle, E B Crewe, N R Swanson, et al.
Hepatology (Baltimore, Md.)|February 3, 2000
Which patients with hepatitis C develop liver complications?M H Khan, G C Farrell, K Byth, et al.
The Medical Journal of Australia|January 2, 1995
Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of responseR L Hope, M Weltman, J Dingley, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Journal of Gastroenterology and Hepatology|September 15, 1998
Effects of hepatitis G virus coinfection on severity of hepatitis C: relationship to risk factors and response to interferon treatmentR Lin, U Dutta, S Kaba, et al.
The Journal of Biological Chemistry|January 10, 1979
Incorporation of exogenous heme into hepatic cytochrome P-450 in vivoM A Correia, G C Farrell, R Schmid, et al.
Australian and New Zealand Journal of Medicine|June 27, 2000
Risk factors for development of hepatocellular carcinoma among Australians with hepatitis C: a case-control studyU Dutta, K Byth, J Kench, et al.
Journal of Viral Hepatitis|May 30, 2008
Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver diseaseH Poustchi, A Mohamadkhani, S Bowden, et al.
Australian and New Zealand Journal of Medicine|June 1, 1991
Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?R Lin, M N Schoeman, P I Craig, et al.
International Journal of Obesity (2005)|March 10, 2011
Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie miceK S Bell-Anderson, L Aouad, H Williams, et al.
Journal of Gastroenterology and Hepatology|October 30, 1998
Molecular epidemiology of hepatitis C in AustraliaS Kaba, U Dutta, K Byth, et al.
The Medical Journal of Australia|September 3, 1990
Does hepatitis C virus play a role in "non-viral" chronic liver disease?C Liddle, E B Crewe, N R Swanson, et al.
Hepatology (Baltimore, Md.)|February 3, 2000
Which patients with hepatitis C develop liver complications?M H Khan, G C Farrell, K Byth, et al.
The Medical Journal of Australia|January 2, 1995
Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of responseR L Hope, M Weltman, J Dingley, et al.
Pageof 17